Factors associated with sinus bradycardia during crizotinib treatment: a retrospective analysis of two large-scale multinational trials (PROFILE 1005 and 1007).

Cancer Med · 2016 · PMC4831279 · PMID 26823131

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

This suggests that the concomitant use of beta‐blockers increases the risk of developing SB during crizotinib treatment, although this association did not reach statistical significance in the multivariable logistic regression analysis.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.